Tanaka et al. [30] found that high expression levels of miR-183 in various types of gliomas are also associated with a downregulation of IDH2, which has complementary sequences to miR-183 in its 3′-untranslated region. This evidence concerns the gene IDH2 and central nervous system cancer.